|
2023
|
Invention
|
An inhaler comprising a retention element. There is provided an inhaler (200) comprising a housin... |
|
|
G/S
|
Inhalable pharmaceutical preparations for the treatment of pain, inflammation, and fever Inhaler ... |
|
|
G/S
|
Inhalable pharmaceutical preparations. Inhaler for pharmaceutical preparations. |
|
|
G/S
|
Inhalable pharmaceutical preparations
Inhaler for pharmaceutical preparations |
|
|
Invention
|
Dry powder formulations for inhalation. A respirable dry powder can include acetylsalicylic acid ... |
|
|
Invention
|
Dry powder formulations for inhalation.
A respirable dry powder including acetylsalicylic acid i... |
|
2021
|
Invention
|
Dry powder compositions with magnesium stearate.
A stable dry powder composition for inhalation ... |
|
2020
|
Invention
|
Dry powder formulations for inhalation. A respirable dry powder including acetylsalicylic acid in... |
|
2019
|
Invention
|
Inhaled aspirin and magnesium to treat inflammation. A stable dry powder composition for inhalati... |
|
|
Invention
|
Treating inflammation with inhaled aspirin. The subject technology relates generally to pulmonary... |
|
|
Invention
|
Dry powder inhaler and methods of use.
Methods for reducing the risk of a thromboembolic event, ... |
|
|
Invention
|
Dry powder compositions with magnesium stearate. A stable dry powder composition for inhalation i... |
|
2018
|
Invention
|
Dry powder formulations and methods of use. The subject technology relates generally to pulmonary... |
|
2017
|
Invention
|
Dry powder inhalation device. Delivery of a dry powder via inhalation can be performed using an i... |
|
2013
|
Invention
|
Dry powder formulations and methods of use. A respirable dry powder can include acetylsalicylic a... |
|
|
Invention
|
Dry powder inhaler and methods of use. Methods for reducing the risk of a thromboembolic event, a... |
